References
- Landis SH, Murray T, Bolden S, Wingo PA. Cancer Statis-tics. CA Cancer J Clin 1999; 49: 8–31.
- Judkins AF, Singletary SE. Surveillance studies and long-term follow-up care. In: Singletary SE, ed. Breast cancer. New York: Springer Ed, 1999: 231–8.
- Grunfeld E, Gray A, Mant D. Follow-up of breast cancer in primary care vs. specialist care: results of an economic evalu-ation. Br J Cancer 1999; 79: 1227–33.
- Spratt JS, Chang AFC, Heuser LS. Carcinoma of the breast. Surg Gynecol Obstet 1983; 157: 220–2.
- Tomiak E, Piccart M. Routine follow-up of patients after primary therapy for early breast cancer: changing concepts and challenges for the future. Ann Oncol 1993; 4: 199–204.
- Richert-Boe KE. Heterogeneity of cancer surveillance prac-tices among medical oncologists in Washington and Oregon. Cancer 1995; 75: 2605–12.
- Loomer L, Brockschmidt JK, Muss HB, Saylor G. Postopera-tive follow-up of patients with early breast cancer. Patterns of care among clinical oncologists and a review of the literature. Cancer 1997; 67: 55–60.
- Hughes LE, Courtney SP. Follow-up of patients with breast cancer. Br Med J 1985; 290: 1229–30.
- Ahearne PM, Leach SD, Feig BW. Invasive breast cancer. In: Feig BW, Berger DH, Fuhrman GM. The MD Anderson Surgical Oncology Handbook 2nd ed. Philadelphia: Lippin-cott Williams & Wilkins, Patel: 13–37.
- The GIVIO Investigators. Impact of follow-up testing on survival and health-related quality of life in breast cancer patients. JAMA 1994; 271: 1587–92.
- Schapira DV. Breast cancer surveillance-a cost-effective strategy. Breast Cancer Res Treat 1993; 25: 107–11.
- Del Turco MR, Palli D, Cariddi A. Intensive diagnostic follow-up after treatment of primary breast cancer-a ran-domized trial. JAMA 1994; 271: 1593–7.
- Donegan WL. Follow-up after treatment for breast cancer-how much is too much? J Surg Oncol 1995; 59: 211–4.
- Khfagy MM, Schottenfeld D, Robbins GF. Prognosis of the second breast cancer. The role of previous exposure to the first primary. Cancer 1975; 35: 596–9.
- Loprinzi CL. Follow-up testing for curatively treated cancer survivors. What to do? JAMA 1995; 273: 1877–8.
- Dewar J. Follow-up in breast cancer. Br Med J 1995; 310: 685–6.
- Dewar JA, Kerr GR. Value of routine follow-up of women treated for early carcinoma of the breast. Br Med J 1985; 291: 1464–7.
- ASCO Special Article. Recommended breast cancer surveil-lance guidelines. J Clin Oncol 1997; 15: 2149–56.
- Zwaveling A, Albers GMR, Felthius W. An evaluation of routine follow-up for detection of breast cancer recurrences. J Surg Oncol 1987; 34: 194–7.
- Scanlon EF, Ovieda MA, Cunningham MP. Preoperative and follow-up procedures on patients with breast cancer@Cancer 1980; 46: 977–9.
- Schapira DV, Urban N. A minimalist policy for breast cancer surveillance. JAMA 1991; 265: 380–2.
- Winchester DP, Sener SF, Khanderkar JD. Symptomatology as an indicator of recurrent or metastatic breast cancer. Cancer 1979; 43: 956–60.
- Pandya KJ, McFadden ET, Kalish LA. A retrospective study of earliest indicators of recurrence in patients on Eastern Cooperative Oncology Group adjuvant chemotherapy trials for breast cancer: a preliminary report. Cancer 1985; 55: 202–5.
- Mansi JL, Earl HM, Powles TJ, Coombes RC. Tests for detecting recurrent disease in the follow-up of patients with breast cancer. Breast Cancer Res Treat 1988; 11: 249–54.
- Kanemura S, Tsuji I, Ohuchi N. A case control study on the effectiveness of breast cancer screening by clinical examina-tion in Japan. Jpn J Cancer Res 1999; 90: 607–13.
- Jatoi I. Breast cancer screening. Am J Surg 1999; 177: 518–24.
- Tomin R, Donegan WL. Screening for recurrent breast can-cer-its effectiveness and prognostic value. J Chin Oncol 1987; 5: 62–7.
- Ormiston MC, Timoney AG, Quereshi AR. Is follow-up of patients after surgery for breast cancer worthwhile? J R Soc Med 1985; 78: 920–1.
- Muss HB, McNamara MJC, Connelly RA. Follow-up after stage II breast cancer: a comparative study of relapsed versus non-relapsed patients. Am J Clin Oncol 1988; 11: 451–5.
- Mushlin Al. The use of diagnostic tests for screening and evaluating breast lesions. Ann Intern Med 1985; 103: 147–51.
- Sakorafas GH, Farley DR, Portales A. Breast conservation therapy for breast cancer. Atlas of therapeutic intervention. Athens: Lagos Medical Publications (in press).
- Recht A, Schnitt SJ, Connolly JL. Prognosis following local or regional recurrence after conservative surgery and radio-therapy for early stage breast carcinoma. Int J Radiat Oncol Biol Phys 1989; 16: 3–9.
- Fowble B, Solin L, Shultz DJ. Breast recurrence following conservative surgery and radiation: patterns of failure, prog-nosis, and pathologic findings from mastectomy specimens with implications for treatment. Int J Radiat Oncol Biol Phys 1990; 19: 833–42.
- Hassell PR, Olivotto IA, Mueller HA Farly breast cancer: detection of recurrence after conservative surgery and radia-tion therapy. Radiology 1990; 176: 731–5.
- Orel SG, Fowble BL, Solin U. Breast cancer recurrence after lumpectomy and radiation therapy for early-stage disease: prognostic significance of detection method. Radiology 1993; 188: 189–94.
- Dershaw DD, McCormick B, Osborne MP. Detection of local recurrence after conservative therapy for breast car-cinoma. Cancer 1992; 70: 493–6.
- Sakorafas GH. Breast cancer. Monograph. Athens: Lagos Medical Publications (in press).
- Mellink WA, Holland R, Hendriks JHCL. The contribution of routine follow-up mammography to an early detection of asynchronous contralateral breast cancer. Cancer 1991; 67: 1844–8.
- Senofsky GM, Wanebo HJ, Wilhelm MC. Has monitoring of the contralateral breast improved the prognosis in patients treated for primary breast cancer? Cancer 1986; 57: 597–602.
- Gail MH, Costantino JP, Bryant J. Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer. J Natl Cancer Inst 1999; 91: 1829–46.
- Cummings SR, Eckert S, Krueger KA. The effect of ralox-ifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple outcomes of raloxifene evaluation. JAMA 1999; 281: 2189–97.
- Yek KA, Fortunato L, Ridge JA. Routine bone scanning in patients with Ti and T2 breast cancer: a waste of money. Ann Surg Oncol 1995; 3: 319–24.
- Anonymous. Clinical practice guidelines for the use of tumor markers in breast and colorectal cancer by the American Society of Clinical Oncology. J Clin Oncol 1996; 14: 2843–77.
- Grunfeld E, Mant D, Vessey MP, Fitzpatrick R Specialist and general practice views on routine follow-up of breast cancer patients in general practice. Fam Pract 1995; 12: 60–5.
- Worster A, Bass MJ, Wood ML. A willingness to follow breast cancer: a survey of family physicians. Can Fam Phys 1996; 42: 263–8.
- Worster A, Wood ML, McWhinney IR, Bass MJ. Who provides follow-up care for patients with early breast cancer? Can Fam Phys 1995; 41: 1314–20.
- Grunfeld E, Mant D, Yudkin P. Routine follow-up of breast cancer in primary care: randomized trial. Br Med J 1996; 313: 665–9.
- McWhinney IR, Hoddinott SN, Bass MJ. Role of the family physician in the care of cancer patients. Can Fain Phys 1990; 36: 2183–6.
- Frampton J, Wall S. Exploring the use of NPs and PAs in primary care. HMO Pract 1994; 8: 165–70.
- Porter HB. The effect of ambulatory oncology nursing prac-tice models on health resource utilization. Part 1. Collabora-tion or compliance? J Nurs Admin 1995; 2: 2521–9.
- Stark ME, Crowe JP. Breast cancer evaluation and follow-up. A survey of the Ohio Chapter of the American College of Surgeons. Am Surg 1996; 62: 458–60.
- Kagan AR, Stechel RT. Routine imaging studies for the post-treatment surveillance of breast and colon cancer. J Chin Oncol 1991; 9: 837–42.